Literature DB >> 17567700

Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire.

Huan H Nguyen1, Michael Zemlin, Ivaylo I Ivanov, Judit Andrasi, Cosima Zemlin, Huong L Vu, Robert Schelonka, Harry W Schroeder, Jiri Mestecky.   

Abstract

Heterosubtypic immunity (HSI) is defined as cross-protection to infection with an influenza A virus serotype other than the one used for primary infection. Although HSI has been thought to be mediated by serotype cross-reactive cytotoxic T lymphocytes (CTL) that recognize conserved epitopes of structural proteins, recent studies suggest that antibodies (Abs) may make a significant contribution. In this study, we provide further evidence for the role of Abs in HSI using transgenic mice lacking terminal deoxyribonucleotidyltransferase (TdT), which adds N nucleotides to V-D and D-J junctions of the complementary determining region 3 (CDR3) (TdT(-/-)) and mice with altered Ab repertoires due to replacement of the complete locus of heavy chain diversity segments (D(H)) with an altered D(H) segment (namely, Delta D-iD). Both types of mice failed to generate complete HSI, although they were able to mount protective immunity to a homologous challenge. Lower levels of virus-specific antibodies along with more severely impaired HSI were observed in TdT(-/-) mice compared to those in Delta D-iD mice, while CTL activity remained unchanged in both types of mice. These findings indicate that a properly diversified antibody repertoire is required for HSI and that N addition by TdT is a more effective mechanism in the induction of a properly diversified antibody repertoire and, therefore, complete HSI. The results suggest that the diversity of the antibody repertoire as determined by the composition of the D region of HCDR3 and by N addition are among the mechanisms selected for in evolution to create a favorable environment to resolve infections with mutated viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567700      PMCID: PMC1951409          DOI: 10.1128/JVI.00751-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.

Authors:  Adrianus C M Boon; Gerrie de Mutsert; Debbie van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Autoantibodies in mice lacking terminal deoxynucleotidyl transferase: evidence for a role of N region addition in the polyreactivity and in the affinities of anti-DNA antibodies.

Authors:  S Weller; C Conde; A M Knapp; H Levallois; S Gilfillan; J L Pasquali; T Martin
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

3.  A universal influenza A vaccine based on the extracellular domain of the M2 protein.

Authors:  S Neirynck; T Deroo; X Saelens; P Vanlandschoot; W M Jou; W Fiers
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

4.  Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system.

Authors:  N Baumgarth; O C Herman; G C Jager; L Brown; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro.

Authors:  K Mozdzanowska; M Furchner; G Washko; J Mozdzanowski; W Gerhard
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 6.  Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Authors:  P C Doherty; D J Topham; R A Tripp; R D Cardin; J W Brooks; P G Stevenson
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

7.  Modified M2 proteins produce heterotypic immunity against influenza A virus.

Authors:  A M Frace; A I Klimov; T Rowe; R A Black; J M Katz
Journal:  Vaccine       Date:  1999-05-04       Impact factor: 3.641

8.  Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.

Authors:  M A Bründler; P Aichele; M Bachmann; D Kitamura; K Rajewsky; R M Zinkernagel
Journal:  Eur J Immunol       Date:  1996-09       Impact factor: 5.532

9.  Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.

Authors:  K Mozdzanowska; K Maiese; M Furchner; W Gerhard
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

10.  Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.

Authors:  H H Nguyen; Z Moldoveanu; M J Novak; F W van Ginkel; E Ban; H Kiyono; J R McGhee; J Mestecky
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

View more
  31 in total

1.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

Review 2.  Polymerases in nonhomologous end joining: building a bridge over broken chromosomes.

Authors:  Dale A Ramsden
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

3.  HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence.

Authors:  Yuge Wang; Pratibha Kapoor; Robert Parks; Aaron Silva-Sanchez; S Munir Alam; Laurent Verkoczy; Hua-Xin Liao; Yingxin Zhuang; Peter Burrows; Michael Levinson; Ada Elgavish; Xiangqin Cui; Barton F Haynes; Harry Schroeder
Journal:  Immunogenetics       Date:  2015-12-19       Impact factor: 2.846

Review 4.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

5.  Regulation of repertoire development through genetic control of DH reading frame preference.

Authors:  Michael Zemlin; Robert L Schelonka; Gregory C Ippolito; Cosima Zemlin; Yingxin Zhuang; G Larry Gartland; Lars Nitschke; Jukka Pelkonen; Klaus Rajewsky; Harry W Schroeder
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  Nucleotide Composition of Human Ig Nontemplated Regions Depends on Trimming of the Flanking Gene Segments, and Terminal Deoxynucleotidyl Transferase Favors Adding Cytosine, Not Guanosine, in Most VDJ Rearrangements.

Authors:  Tina Funck; Mike Bogetofte Barnkob; Nanna Holm; Line Ohm-Laursen; Camilla Slot Mehlum; Sören Möller; Torben Barington
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

7.  Terminal deoxynucleotidyl transferase is required for an optimal response to the polysaccharide α-1,3 dextran.

Authors:  Tamer I Mahmoud; John F Kearney
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

Review 8.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

9.  Preferential use of DH reading frame 2 alters B cell development and antigen-specific antibody production.

Authors:  Robert L Schelonka; Michael Zemlin; Ryoki Kobayashi; Gregory C Ippolito; Yingxin Zhuang; G Larry Gartland; Alex Szalai; Kohtaro Fujihashi; Klaus Rajewsky; Harry W Schroeder
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  Case-based surveillance of influenza hospitalizations during 2004-2008, Colorado, USA.

Authors:  Rosemary Proff; Ken Gershman; Dennis Lezotte; Ann-Christine Nyquist
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.